CIK 0000885725
- Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042695240
- Phone
- +1 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-22 | Sorenson John Bradley SVP, Manuf & Sup Chn | Grant or award · Performance Share Units | +4,202 | 4,202 | ||
| 2021-02-22 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion | +1,159 | 15,993 | ||
| 2021-02-22 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Shares withheld for taxes | −338 | $39.20 | $13K | 15,655 |
| 2021-02-22 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion · Deferred Stock Units | −1,159 | 0 | ||
| 2021-02-22 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Grant or award · Performance Share Units | +3,940 | 3,940 | ||
| 2021-02-22 | Ralls-Morrison Desiree SVP, GC and Corp Secretary | Grant or award · Performance Share Units | +6,041 | 6,041 | ||
| 2021-02-22 | Pierce David A EVP Pres MedSurg | Exercise or conversion | +2,607 | 13,653 | ||
| 2021-02-22 | Pierce David A EVP Pres MedSurg | Shares withheld for taxes | −1,157 | $39.20 | $45K | 12,496 |
| 2021-02-22 | Pierce David A EVP Pres MedSurg | Exercise or conversion · Deferred Stock Units | −2,607 | 0 | ||
| 2021-02-22 | Pierce David A EVP Pres MedSurg | Grant or award · Performance Share Units | +9,456 | 9,456 | ||
| 2021-02-22 | Nanavaty Maulik SVP & Pres, Neuromodulation | Exercise or conversion | +1,883 | 244,648 | ||
| 2021-02-22 | Nanavaty Maulik SVP & Pres, Neuromodulation | Shares withheld for taxes | −652 | $39.20 | $26K | 243,996 |
| 2021-02-22 | Nanavaty Maulik SVP & Pres, Neuromodulation | Exercise or conversion · Deferred Stock Units | −1,883 | 0 | ||
| 2021-02-22 | Nanavaty Maulik SVP & Pres, Neuromodulation | Grant or award · Performance Share Units | +6,303 | 6,303 | ||
| 2021-02-22 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion | +1,159 | 36,835 | ||
| 2021-02-22 | Monson Jonathan VP, Global Controller and CAO | Shares withheld for taxes | −353 | $39.20 | $14K | 36,482 |
| 2021-02-22 | Monson Jonathan VP, Global Controller and CAO | Exercise or conversion · Deferred Stock Units | −1,159 | 0 | ||
| 2021-02-22 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion | +2,318 | 139,108 | ||
| 2021-02-22 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Shares withheld for taxes | −1,058 | $39.20 | $41K | 138,050 |
| 2021-02-22 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Exercise or conversion · Deferred Stock Units | −2,318 | 0 |
Page 97 of 104 · 2,069 trades